WILLIAM MILLER, MD
Osteopathic Medicine at Ritter Ave, Indianapolis, IN

6803484, Oct 12, 2004

Dec 24, 2003

10/746164

James Abraham Aikins - Pendleton IN
Andrew Hendley Fray - Indianapolis IN
William David Miller - Indianapolis IN

Eli Lilly and Company - Indianapolis IN

C07C31103

564 97, 514605, 564 99

The present invention relates to a compound of formula (Ia) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders.

4138181, Feb 6, 1979

Apr 25, 1978

5/899945

John R. Hacker - Indianapolis IN
Chris W. Krohne - Indianapolis IN
William H. Miller - Indianapolis IN

The United States of America as represented by the Secretary of the Navy - Washington DC

H01R 1362

339 45R

A releasable electrical connector having a receptacle component and a plug omponent which can be mated and disconnected by relative rotation between components and can be separated by a straight breakaway force. The receptacle component is provided with bayonet pins that engage semicircular holes in a spring-biased sleeve positioned in the plug component. One end of the spring-biased sleeve is divided into sections and two opposed sections are permanently bent outwardly at an angle sufficiently large so as to clear the bayonet pins on the receptacle component. The semi-circular holes used for locking the bayonet pins are provided in the bent sections and a boss on the interior surface of the plug component compresses the bent sections to lock the bayonet pins in the semi-circular holes. A breakaway force moves the sleeve outwardly from the boss and, when the bent sections clear the boss, the resilient bent sections spring outwardly to release the bayonet pins.

5387681, Feb 7, 1995

Aug 19, 1992

7/932404

William D. Miller - Indianapolis IN
Eddie V. P. Tao - Carmel IN

Eli Lilly and Company - Indianapolis IN

C07D23304

544106

This invention provides a novel process for the synthesis of bicyclic aromatic sulfonic acids employing reacting a bicyclic aromatic compound with sulfur trioxide-N,N-dimethylformamide complex in the presence of a water miscible, non-reactive solvent. The resulting sulfonic acid may be converted into the corresponding sulfonyl halide by the reaction with a thionyl halide. This invention further provides a novel process for the synthesis of bicyclic aromatic sulfonamides employing the reaction conditions described supra followed by an ammonolysis or amination.

7034045, Apr 25, 2006

Apr 17, 2000

09/958262

David Michael Bender - Indianapolis IN, US
Buddy Eugene Cantrell - Zionsville IN, US
Andrew Hendley Fray - Indianapolis IN, US
Winton Dennis Jones - Carmel IN, US
William David Miller - Indianapolis IN, US
David Mitchell - Indianapolis IN, US
Richard Lee Simon - Greenwood IN, US
Hamideh Zarrinmayeh - Carmel IN, US
Dennis Michael Zimmerman - Zionsville IN, US

Eli Lilly and Company - Indianapolis IN

A61K 31/44, A61K 31/40, A61K 31/38, A61K 31/275, A61K 31/195

514355, 514357, 514429, 514438, 514523, 514524, 514539, 514562, 514597, 514605, 546316, 548577, 558408, 558413, 560 12, 560430, 564 49, 564 99

The present invention provides certain monofluoroalkyl derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.